cell
larg
syncyti
group
figur
show
patient
herp
simplex
infect
cervix
cytolog
commonli
use
detect
infect
herp
simplex
viru
hsv
cytomegaloviru
cmv
definit
less
sensit
cultur
direct
examin
virusinfect
tissu
exud
may
perform
specif
fluoresceinlabel
viral
antibodi
test
complet
within
hour
sensit
method
detect
presenc
viral
antigen
howev
perform
test
requir
consider
technolog
expertis
commerci
avail
reagent
quit
variabl
qualiti
fluoresc
antibodi
identif
use
regularli
diagnosi
infect
hsv
varicellazost
vzv
respiratori
syncyti
rsv
rabi
virus
found
vzv
grow
slowli
tissu
cultur
readili
detect
smear
skin
lesion
fluoresc
antibodi
e
hd
mani
laboratori
direct
fa
superior
cultur
diagnosi
vzv
rsv
infect
cultur
two
virus
take
sever
day
may
fals
neg
mani
viral
antigen
may
also
detect
indirect
fluoresc
antibodi
techniqu
recent
develop
invitro
product
monoclon
antibodi
greatli
enhanc
specif
sensit
well
immunodiagnost
method
futur
follow
suggest
approach
direct
diagnosi
fluorescein
isothiocyanateconjug
antisera
reconstitut
phosphatebuff
salin
pb
ph
aliquot
store
time
use
sampl
titrat
dilut
pb
determin
optim
work
dilut
infect
cell
cultur
optim
dilut
defin
give
specif
fluoresc
cell
infect
homolog
viru
fluoresc
cell
infect
heterolog
viru
uninfect
cell
optim
dilut
test
crossreact
heterolog
virus
well
nonspecif
fluoresc
impress
smear
frozen
section
normal
noninfect
human
tissu
brain
lung
clinic
use
appropri
control
includ
preimmun
conjug
deriv
homolog
anim
sourc
conjug
antisera
heterolog
virus
tissu
section
impress
smear
use
normal
noninfect
tissu
control
conjug
use
clinic
specimen
twofold
lower
dilut
type
tissu
cultur
isol
clean
plain
glass
slide
use
frozen
section
impress
smear
examin
resuspend
cell
preprint
slide
prefer
slide
prepar
spray
fluoroglid
four
type
specimen
use
f
diagnosi
frozen
section
impress
smear
lesion
scrape
resuspend
cell
centrifug
sediment
frozen
section
cut
pm
thick
lesion
scrape
best
obtain
scalpel
blade
smear
spot
slide
swab
lesion
may
roll
onto
slide
rub
avoid
distort
cell
morpholog
cell
suspens
usual
readili
recov
urin
bodi
fluid
exampl
amniot
fluid
centrifug
addit
appropri
vigor
appli
collect
swab
respiratori
tract
conjunctiva
vagina
skin
lesion
specimen
viral
transport
media
util
sampl
blend
thoroughli
vortex
mixer
swab
remov
sampl
centrifug
x
g
minut
supernat
use
cell
cultur
inocul
remain
sediment
suspend
enough
pb
without
phenol
red
yield
slightli
turbid
suspens
spot
well
slide
pasteur
pipett
amount
pb
requir
resuspens
usual
vari
ml
slide
label
appropri
allow
airdri
complet
fix
aceton
minut
slide
must
transport
one
laboratori
anoth
may
sent
airdri
ambient
temperatur
acetonefix
formalinfix
tissu
suitabl
f
studi
appropri
dilut
conjug
overlaid
specimen
slide
incub
c
minut
humidifi
chamber
slide
wash
gentl
agit
two
period
pb
cover
slip
mount
buffer
glycerol
ph
specimen
examin
fluoresc
halogensourc
microscop
equip
epifluoresc
ideal
purpos
observ
x
magnif
oil
immers
use
lowfluoresc
oil
necessari
strict
criteria
interpret
fluoresc
pattern
must
appli
exampl
nuclear
cytoplasm
stain
typic
influenza
viru
adenovirus
herp
virus
cytoplasm
stain
seen
rsv
parainfluenza
mump
virus
stain
within
multinucl
giant
cell
typic
measl
virus
pattern
fluoresc
appropri
proper
control
employ
specif
test
high
fact
agent
vzv
direct
f
often
consider
sensit
cultur
falseposit
result
obtain
previous
mention
criteria
strictli
appli
specimen
contain
yeast
mucu
leukocyt
b
e
especi
mislead
also
csf
sediment
result
view
great
caution
leukocyt
sourc
may
possess
fc
receptor
respons
nonspecif
bind
conjug
extrem
import
attempt
viru
isol
specimen
submit
fluoresc
antibodi
stain
verifi
result
enhanc
overal
sensit
diagnosi
properli
standard
conjug
cultur
f
examin
perform
falseneg
f
test
observ
instanc
falseneg
test
result
specimen
low
viru
titer
requir
mani
day
detect
cultur
falseneg
fluoresc
assay
result
occur
critic
specimen
brain
biopsi
hsv
enceph
cultur
backup
therefor
mandatori
addit
direct
detect
viral
antigen
clinic
specimen
immunofluoresc
antibodi
may
also
use
rapidli
detect
presenc
viru
cmv
tissu
cultur
centrifug
urin
onto
tissu
cultur
monolay
stain
hour
inocul
viru
may
detect
without
wait
mani
day
cytopathogen
effect
ee
l
p
solidphas
immunoassay
spia
detect
antigen
antibodi
use
indic
radioact
label
ria
action
enzym
label
substrat
elisa
sever
excel
review
procedur
applic
viral
diagnosi
publish
applic
spia
techniqu
success
appli
detect
hepat
b
rotaviru
hepat
antibodi
adenoviru
hsv
rsv
influenza
viru
cmv
group
coxsackieviru
commerci
kit
avail
detect
rotavirus
well
hb
ag
hb
ab
hb
ab
hav
igm
igg
fluid
specimen
appropri
detect
viral
antigen
elisa
serum
may
use
directli
test
urin
fece
may
need
homogen
salin
preliminari
clarif
centrifug
suitabl
test
nasopharyng
sputum
specimen
collect
appropri
transport
media
dilut
per
cent
nacetyl
cystein
use
test
radioimmunoasa
use
detect
hepat
b
herp
simplex
antigen
tissu
cultur
recent
immunolog
techniqu
elisa
appli
detect
viral
antigen
directli
cultur
enzym
immunoassay
provid
advantag
rel
stabl
nonradioact
reagent
result
either
qualit
quantit
elisa
usual
sensit
assay
except
ria
equip
necessari
elisa
quit
simpl
object
major
drawback
spia
qualiti
specimen
respiratori
genit
skin
swab
assess
mark
contrast
specif
disadvantag
elisa
includ
variabl
solidphas
carrier
carcinogen
certain
chromogen
substrat
ria
requir
expens
equip
also
involv
exposur
carcinogen
addit
dispos
hazard
materi
pose
consider
difficulti
spia
also
requir
day
overnight
incub
sever
wash
procedur
optim
use
spia
rapid
viral
diagnosi
sever
specimen
examin
antigen
given
run
thu
techniqu
best
suit
diseas
viral
gastroenter
viral
hepat
respiratori
infect
mani
specimen
submit
laboratori
given
time
although
singl
specimen
could
analyz
quit
often
altern
assay
em
might
appropri
sever
review
procedur
util
electron
microscopi
em
diagnost
virolog
publish
lo
procedur
surprisingli
simpl
experienc
electron
microscopist
complet
within
minut
receipt
specimen
would
inappropri
purchas
electron
microscop
sole
diagnost
virolog
laboratori
exist
electron
microscop
institut
could
use
em
techniqu
applic
investig
viral
infect
titer
viru
specimen
least
particl
per
ml
em
commonli
util
fece
examin
rotavirus
well
nonvalk
agent
adenovirus
coronavirus
calicivirus
mav
seen
identifi
caus
ill
nonvalk
agent
viru
import
caus
gastroenter
easili
visibl
standard
em
fece
usual
requir
enhanc
immun
em
permit
detect
iinmun
em
allow
visual
viru
particl
may
present
number
small
easi
direct
detect
addit
specif
antiserum
test
suspens
caus
viru
particl
form
antibodybound
aggreg
easili
detect
e
singl
viru
particl
specimen
vesicl
fluid
brain
tissu
solid
warti
tissu
urin
serum
neg
stain
minimuin
prepar
yield
posit
result
concentr
virus
lower
specimen
other
techniqu
enhanc
visual
necessari
enhanc
techniqu
may
includ
pseudorepl
agar
gel
diffus
ultracentrifug
immun
em
diseas
em
play
role
rapid
diagnosi
includ
gastroenter
herp
simplex
infect
varicellazost
especi
immuncomromis
e
n
congenit
cmv
infect
hepat
b
molluscum
contagiosum
wart
instanc
virus
seen
em
detect
altern
method
exampl
hsv
vzv
viral
antigen
detect
f
techniqu
rotaviru
stool
specimen
detect
latex
agglutin
elisa
counterimmunoelectroosmophoresi
nonetheless
em
quit
use
diagnost
virolog
laboratori
especi
examin
fece
patient
gastroenter
becausein
addit
rotavirusesnorwalk
viru
adenovirus
coronavirus
calicivirus
inav
seen
identifi
caus
ill
em
also
use
detect
herpesviru
particl
brain
biopsi
patient
enceph
cmv
particl
may
seen
high
concentr
urin
congenit
infect
infant
may
requir
form
enhanc
em
detect
although
hepat
b
viral
particl
seen
serum
em
sensit
conveni
method
viral
antigen
detect
ria
elisa
usual
employ
human
papilloma
viru
common
wart
orf
viru
inolluscum
contagiosum
poxviru
view
homogen
solid
biopsi
tissu
examin
specimen
rare
indic
finallv
em
use
hasten
identif
viru
recov
tissu
cultur
detect
viral
mycoplasma
contamin
cell
cultur
specimen
collect
prepar
specimen
collect
describ
subsequ
transport
ambient
temperatur
seal
contain
drevent
drving
fluid
specimen
depend
upon
type
clinic
specimen
centrifug
may
help
provid
better
prepar
fece
prepar
make
per
cent
suspens
distil
water
clarifi
bench
centrifug
necessari
vesicl
fluid
collect
unbroken
lesion
use
tuberculin
syring
contain
small
amount
distil
water
sheath
place
needl
tape
appli
plunger
sheath
syring
transport
laboratori
insid
appropri
contain
urin
cloudi
clarifi
centrifug
x
g
minut
supernat
fluid
usual
yield
viru
readili
larg
volum
possibl
exampl
mli
centrifug
hour
x
g
resuspend
pellet
stain
techniqu
enhanc
mention
subsequ
proven
use
urin
specimen
serum
contain
mani
lowmolecularweight
protein
need
wash
dilut
equal
volum
distil
water
urin
centrifug
hour
x
g
necessari
serum
may
even
requir
recentrifug
provid
clean
specimen
tissu
specimen
biopsi
autopsi
tissu
cut
small
cube
place
metal
planchet
freez
thaw
five
cycl
altern
method
involv
mechan
homogen
use
mortar
pestl
homogen
rel
smooth
suspens
achiev
mix
homogen
small
amount
distil
water
use
finebor
pasteur
pipett
best
result
achiev
differenti
centrifug
stain
supernat
fluid
phosphotungst
acid
specimen
less
commonli
examin
specimen
may
submit
em
examin
conjunctiv
scrape
usual
contain
small
amount
tissu
csf
seldom
yield
viru
specimen
process
directli
without
centrifug
sputum
specimen
dilut
salin
homogen
treat
per
cent
nacetyl
cystein
differenti
centrifug
form
enhanc
usuallv
necessarv
concentr
secimen
stain
appropri
laboratori
techniqu
examin
clinic
specimen
neg
stain
commonli
use
stain
phosphotungst
acid
per
cent
solut
adjust
ph
n
otassium
hvdroxid
store
work
solut
formvarcarbonco
copper
grid
provid
versatil
carrier
specimen
view
techniqu
involv
place
r
steril
distil
water
wax
surfac
grid
held
bv
fine
forclp
touch
drop
held
upright
stainld
op
phosphotungst
acid
excess
fluid
remov
torn
strip
filter
paper
specimen
dri
examin
em
total
process
take
minut
techniqu
enhanc
viru
ation
techniqu
devis
enhanc
sensit
em
detect
virus
includ
pseudorepl
agar
gel
diffus
concentr
rotavirus
fece
cmv
urin
ultracentrifug
immun
em
also
employ
concentr
rubella
viru
nonvalk
agent
hepat
viru
decad
ago
serolog
util
primari
procedur
diagnos
viral
infect
recent
approach
replac
mani
case
method
design
detect
viral
agent
antigen
quickli
possibl
howev
sever
situat
still
exist
serolog
diagnosi
extrem
help
acutephas
serum
virolog
workup
plan
individu
patient
gener
use
obtain
least
ml
acutephas
serum
store
freezer
may
becom
valuabl
particularli
viru
detect
subsequ
fail
interpret
isol
equivoc
instanc
convalescentphas
serum
may
request
week
first
appropri
select
antigen
test
made
singl
sera
case
singl
serum
may
studi
appropri
interpret
virusspecif
immunoglobulin
igm
antibodi
usual
rise
first
week
infect
persist
sever
week
month
eventu
becom
replac
igg
antibodi
thu
elev
titer
specif
igm
antibodi
suggest
recent
primari
infect
viru
question
may
support
demonstr
fall
igm
antibodi
followup
sera
detect
specif
igm
use
success
diagnosi
infect
due
vzv
eusteinbarr
viru
ebv
cmv
rubella
coxsackievirus
current
procedur
choic
establish
recent
activ
infect
due
hepat
method
employ
igmspecif
antibodi
determin
vari
consider
includ
sucros
densiti
gradient
centrifug
column
chromatographi
staphylococc
protein
absorpt
solidphas
immunoassay
f
assay
elisa
ria
method
vari
sensit
conveni
applic
sever
limit
interuret
must
keut
mind
recogn
u
igmspecif
antibodi
respons
alway
restrict
primari
infect
reactiv
reinfect
may
result
igm
respons
particularli
cmv
hsv
ebv
vzv
infect
addit
patient
may
continu
uroduc
igmspecif
antibodi
rubella
cmv
mani
month
primari
infect
heterotyp
igm
respons
also
occurfor
exampl
antibodi
respons
cmv
ebv
infect
vice
versa
pitfal
includ
fals
low
neg
igm
titer
due
competit
igg
antibodi
antigenbind
site
falseposit
reaction
due
rheumatoid
factor
error
appear
common
solid
phase
assay
employ
falseneg
falseposit
igm
fluoresc
antibodi
result
frequent
encount
screen
sera
newborn
secif
antibodv
cmv
rubella
viru
case
falseposit
result
attribut
rheumatoid
factor
matern
origin
falseneg
result
might
occur
result
colnpetit
high
level
matern
igg
low
level
fetal
igm
cord
area
use
singl
sera
includ
screen
infant
blood
certain
antibodi
igg
class
known
popularli
torch
screen
adequ
knowledg
specif
level
antibodi
titer
achiev
individu
acut
infect
afterward
height
titer
singl
serum
sampl
may
aid
presumpt
diagnosi
recent
infect
exampl
hemagglutinationinhibit
antibodi
titer
greater
western
equin
enceph
st
loui
enceph
viru
complement
fixat
titer
greater
influenza
b
viru
would
support
recent
experi
agent
howev
import
rememb
interpret
criteria
appli
allinfect
titer
mani
virus
persist
vari
level
thu
titer
singl
sera
must
interpret
cautious
case
falseposit
serolog
result
major
serolog
interpret
base
upon
convers
seroneg
posit
fourfold
greater
rise
antibodi
titer
pair
sera
howev
appar
signific
antibodi
titer
rise
may
alway
signific
exampl
occasion
rise
antibodi
cmv
patient
influenza
mycoplasma
pneumonia
infect
suggest
stress
reactiv
cmv
latter
agent
falseposit
serolog
respons
may
also
result
crossreact
relat
antigen
exampl
antibodi
rise
parainfluenza
viru
may
actual
result
infect
mump
viru
also
anamnest
antibodi
respons
may
fals
suggest
seroconvers
caus
appar
fourfold
greater
rise
antibodi
titer
select
antigen
test
pair
sera
case
viru
suspect
detect
sometim
made
basi
clinic
syndrom
known
local
epidemiolog
particular
virus
age
patient
led
concept
serolog
batteri
panel
central
nervou
system
syndrom
hsv
mump
western
equin
enceph
eastern
equin
enceph
st
loui
enceph
california
enceph
virus
perhap
lymphocyt
choriolnening
viru
ebv
may
includ
batteri
test
cn
syndrom
although
herp
simplex
antigen
includ
panel
rise
antibodi
titer
suffici
diagnos
hsv
enceph
larg
share
viral
cn
ill
especi
asept
mening
caus
enteroviru
group
multipl
serotyp
cumbersom
serolog
method
necessari
diagnosi
usual
make
impract
includ
batteri
one
two
enterovirus
shown
epidem
area
one
summer
possibl
pick
addit
case
carri
neutral
test
pair
sera
employ
enteroviru
enterovirus
question
respiratori
syndrom
depend
upon
age
patient
antigen
panel
test
respiratori
syndrom
inight
includ
influenza
b
rsv
parainfluenza
adenovirus
pneumonia
chlamydia
exampl
rsv
parainfluenza
might
routin
test
infant
young
children
adult
exanthem
test
exanthem
antigen
batteri
would
includ
measl
rubella
diseas
vesicular
hsv
vzv
includ
myocard
pericard
antigen
group
b
coxsackieviru
type
perhap
influenza
b
virus
depend
upon
epidemiolog
circumst
would
make
batteri
test
myocard
pericard
although
numer
virus
implic
inflammatori
diseas
heart
cover
membran
group
b
coxsackievirus
type
consid
account
nearli
per
cent
case
unfortun
much
clinic
ill
express
time
standard
method
viru
detect
like
fail
serolog
diagnosi
must
attempt
full
interpret
serolog
result
may
requir
test
presenc
antibodi
sever
differ
antigen
compon
singl
viru
two
notabl
exampl
ebv
hepat
b
viru
instanc
ebv
infect
diagnos
usual
clinic
criteria
heterophil
antibodi
test
specif
antibodi
test
perform
tabl
includ
igg
antibodi
viral
capsid
antigen
vca
appear
earli
infect
usual
persist
acut
hepat
b
viru
infect
primarili
diagnos
detect
surfac
antigen
hb
ag
serum
antibodi
hb
ag
antihb
appear
week
month
viru
elimin
marker
past
infect
rel
immun
reinfect
antibodi
core
antigen
antihb
appear
infect
persist
variabl
period
thereaft
patient
acut
hepat
b
hb
ag
declin
undetect
titer
antihb
may
marker
acut
hepat
b
infect
occur
antihb
yet
develop
patient
said
core
window
antihb
may
persist
long
time
presenc
diagnost
acut
hepat
b
singl
best
test
purpos
gm
antibodi
core
antigen
gm
anti
hb
anoth
compon
hepat
b
viru
known
e
antigen
may
also
sought
hb
agposit
sera
well
correspond
antibodi
presenc
hepat
b
e
antigen
correl
infect
antibodi
consid
marker
lower
risk
transmiss
latter
antigen
test
import
epidemiolog
studi
rare
necessari
perform
clinic
diagnost
purpos
gold
standard
test
prove
etiolog
viral
syndrom
recoveri
agent
tissu
cultur
procedur
surprisingli
simpl
perform
multipl
media
use
bacteriolog
sever
differ
type
tissu
cultur
inocul
viral
specimen
detect
viral
presenc
cultur
accomplish
observ
cytopathogen
effect
cpe
chang
appear
tissu
cultur
cell
experi
technologist
distinguish
cpe
characterist
certain
viru
group
make
presumpt
judgment
viru
isol
judgment
aid
note
sever
tissu
cultur
exhibit
cpe
rapidli
extens
cpe
develop
mani
clinic
situat
presumpt
identif
suffic
final
identif
although
definit
biolog
immunolog
procedur
may
perform
bacteriolog
may
unnecessari
flat
lactosefer
coloni
indoleosit
bacteria
recov
urin
specimen
may
reason
presum
escherichia
coli
similarli
agent
recov
genit
lesion
produc
herpeslik
cpe
sever
type
tissu
cultur
within
day
may
reason
presum
hsv
viral
cultur
routin
incub
day
unless
cmv
suspect
blind
subcultur
specimen
neg
cpe
unnecessari
clinic
laboratori
yield
slight
low
titer
viru
may
reflect
carrier
state
rather
pathogen
relationship
respiratori
tract
cultur
without
cpe
must
hemadsorb
detect
certain
virus
exampl
parainfluenza
mump
may
develop
cpe
procedur
suspens
guinea
pig
red
blood
cell
ad
tube
tissu
cultur
monolay
examin
adher
cell
adher
occur
hemadsorb
viru
may
present
clinic
laboratori
need
maintain
stock
embryon
egg
coloni
suckl
mice
true
certain
virus
certain
serotyp
coxsacki
viru
togavirus
formerli
arbovirus
isol
without
thev
worth
greatlyincreas
effort
clinic
ill
warrant
specimen
cultur
use
system
may
sent
refer
laboratori
common
virus
isol
bv
standard
method
describ
includ
rubella
measl
rotavirus
specimen
patient
suspect
infect
agent
also
sent
refer
laboratori
special
cultur
procedur
case
rotavirus
direct
electron
microscov
antigen
detect
contrast
intrins
delay
serolog
studi
result
viral
cultur
surprisingli
rapid
first
virus
isol
laboratori
requir
averag
day
detect
isol
herp
simplex
influenza
virus
report
within
day
receipt
specimen
herrmanng
report
per
cent
viral
isol
could
report
within
day
specimen
receipt
addit
two
rapid
grower
alreadi
mention
abl
report
two
third
enteroviru
isol
physician
within
day
obtain
specimen
cmv
rsv
regard
slow
grower
past
mayo
clinic
per
cent
rsv
isol
recov
within
day
cultur
recent
hall
improv
rsv
recoveri
directli
inocul
cultur
patient
bedsid
nasal
wash
specimen
use
procedur
tissu
cultur
abl
detect
two
third
rsv
isol
within
day
cultur
bedsid
inocul
seem
key
step
achiev
similar
result
inocul
simpl
nasopharyng
throat
swab
directlv
tissu
cultur
direct
bedsid
inocul
throat
cultur
hospit
also
improv
recoveri
cmv
per
cent
recoveri
day
per
cent
day
direct
inocul
urin
tissu
cultur
occasion
detect
cmv
cpe
within
day
sourc
select
appropri
specimen
complic
sever
differ
virus
may
caus
clinic
diseas
exampl
sever
differ
type
specimen
may
submit
patient
cn
diseas
csf
enteroviru
mump
viru
perhap
hsv
type
throat
enteroviru
stool
rectal
swab
enteroviru
addit
blood
collect
acutephas
specimen
case
subsequ
serolog
test
necessari
mump
viru
hsv
arboviru
mani
consider
howev
allow
clinician
select
appropri
specimen
exampl
summer
enterovir
mening
preval
throat
stool
specimen
certainli
submit
addit
csf
hand
develop
enceph
children
acquisit
sever
mosquito
bite
wood
area
endem
california
enceph
viru
suggest
blood
specimen
antibodi
test
would
optim
exampl
includ
cn
diseas
follow
parot
urin
csf
specimen
mump
viru
focal
enceph
tempor
lobe
local
preced
headach
disorient
brain
biopsi
hsv
hand
respiratori
syndrom
gener
necessari
submit
throatlnasopharyng
specimen
stool
urin
isol
would
irrelev
consider
follow
throat
nasopharyng
swab
aspir
recov
virus
nasopharyng
aspir
superior
swab
latter
consider
conveni
throat
swab
probabl
adequ
recov
enteroand
adenovirus
hsv
wherea
nasopharyng
specimen
definit
superior
recov
rsv
probabl
better
parainfluenza
virus
nasal
specimen
optim
recov
rhinovirus
known
due
virus
cultiv
cell
cultur
fecal
specimen
case
may
examin
noncultur
agent
rotaviru
electron
microscopi
antigen
detect
see
subsequ
discuss
stool
cultur
use
patient
suspect
enteroviru
diseasefor
exampl
asept
mening
myopericard
hand
foot
mouth
diseas
enterovirus
fece
patient
support
definit
prove
agent
caus
ill
avail
evid
indic
stool
specimen
product
rectal
swab
gener
infect
virus
surround
lipid
membran
hsv
cmv
destroy
gastric
acid
therefor
excret
activ
form
fece
urin
cmv
mump
adenoviru
virus
frequent
recov
urin
laboratori
case
cn
diseas
due
mumv
viru
isol
urin
svecimen
site
neg
recoveri
cmv
urin
increas
twoto
threefold
process
sever
specimen
urin
specimen
submit
cultur
cmv
inocul
directlv
cell
cultur
alternativelv
may
centrifug
either
supernat
urin
sediment
resuspend
small
volum
use
inoculum
recent
studi
indic
centrifug
urin
onto
tissu
cultur
monolay
best
r
c
e
u
r
e
gener
examin
urin
sediment
cytomegal
inclusionbear
cell
sensit
method
diagnos
cmv
infect
viral
isol
least
fourfold
sensit
infant
adult
dermal
lesion
fluid
cell
vesicl
superior
specimen
prepar
ulcer
crust
cultur
direct
stain
blood
cmv
viremiakay
present
symptomat
infect
correl
lethal
pneumonia
bone
marrow
transplant
recipi
leukocyt
virus
resid
may
collect
effici
ficollhypaquemacrodex
techniqu
convent
buffycoat
method
anticoagul
blood
clot
use
isol
arbovirus
serum
suitabl
recov
enterovirus
tissu
tissu
explant
cell
grown
cell
cultur
dispers
cell
tissu
fragment
provid
higher
rate
viral
isol
homogen
specimen
presum
viral
inhibitor
may
releas
homogen
result
lower
recoveri
rate
disrupt
cell
lung
cmv
influenza
viru
adenoviru
brain
hsv
product
tissu
sourc
viral
isol
urin
sediment
cytolog
detect
cmv
inclus
tissu
least
three
six
time
less
sensit
viral
isol
time
specimen
collect
proper
time
specimen
collect
essenti
adeauat
recoverv
virus
svecimen
collect
earli
acut
phase
infect
studi
respiratori
virus
indic
mean
durat
viral
shed
may
day
also
hsv
vzv
may
recov
lesion
beyond
day
onset
isol
enteroviru
csf
may
product
within
day
onset
cn
manifest
transport
specimen
laboratori
shorter
interv
collect
specimen
deliveri
laboratori
greater
potenti
isol
agent
feasibl
inocul
specimen
blood
fece
tissu
cultur
tube
patient
bedsid
transport
laboratori
promptli
materi
may
use
swab
howev
calcium
algin
may
inactiv
hsv
gener
follow
statement
hold
may
except
never
leav
specimen
room
incub
temperatur
imposs
deliv
specimen
immedi
refriger
pack
shave
ice
deliveri
laboratori
within
hour
collect
sever
type
media
use
transport
viral
specimen
select
purpos
base
either
tradit
data
obtain
test
surviv
laboratori
strain
viru
recent
doubleblind
prospect
studi
compar
recoveri
virus
upper
respiratori
tract
dermal
lesion
children
use
three
type
transport
media
show
statist
signific
differ
modifi
stuart
modifi
hank
liebovitzemori
media
gener
believ
protein
serum
albumin
gelatin
incorpor
transport
medium
enhanc
surviv
virus
transit
howev
two
studi
indic
hsv
surviv
well
stuart
hank
proteinfre
culturett
modifi
stuart
bacteri
transport
medium
marion
laboratori
inc
kansa
citi
mo
appear
satisfactori
shortterm
hour
transport
improp
storag
significantli
reduc
viral
cultur
yield
freezethaw
cycl
signific
loss
infect
titer
occur
lipidenvelop
virus
hsv
cmv
agent
adenoand
enterovirus
coat
protein
exampl
laboratori
strain
hsv
held
day
thaw
reduct
infecti
titer
contrast
store
day
hank
broth
medium
loss
infect
two
third
anoth
studi
per
cent
strain
cmv
fail
produc
cytopath
effect
storag
day
storag
room
temperatur
unsatisfactori
altern
specimen
receiv
laboratori
cryoprotect
sorbitol
may
ad
even
viral
suspens
must
frozen
thaw
rigid
condit
freez
per
minut
thaw
achiev
maximum
recoveri
viru
thu
shortterm
less
day
transit
storag
specimen
viral
cultur
held
rather
frozen
primari
monkey
kidney
pmk
excel
system
recoveri
myxovirus
mani
enterovirus
also
may
support
growth
adenovirus
rsv
measl
virus
cell
occasion
contamin
simian
virus
commonli
sv
sv
problem
minim
addit
antisera
agent
cell
cultur
media
human
fetal
diploid
hfd
exampl
foreskin
fibroblast
fig
fibroblast
cell
dual
advantag
rel
inexpens
suscept
broad
spectrum
virus
use
isol
vzv
hsv
adenoviru
picornaviru
rsv
cell
cmv
recov
continu
cell
line
epitheli
cell
deriv
human
cancer
excel
cell
system
recov
adenoviru
hsv
especi
rsv
avail
commerci
cell
cultur
media
greatli
facilit
work
involv
viru
isol
purchas
commerci
upon
figur
normal
diploid
fibroblast
tissu
cultur
cell
arriv
laboratori
tube
examin
microscop
adequ
monolay
cell
present
growth
medium
replac
ml
fresh
mainten
medium
prior
storag
monolay
incomplet
growth
medium
replac
ml
fresh
growth
medium
h
f
cultur
prepar
clinic
laboratori
rather
purchas
commerci
major
clinic
signific
virus
recov
cell
svstem
describ
reviouslv
secimen
submit
isol
virus
requir
type
cell
cultur
exampl
coxsacki
togavirus
forward
refer
laboratori
laboratori
refer
addit
cell
cultur
rd
rhabdomvosarcoma
bgm
continu
monkey
kidney
recov
coxsackik
b
virus
respect
interpret
virolog
data
must
base
knowledg
normal
viral
flora
site
sampl
clinic
find
epidemiolog
behavior
virus
situat
serolog
studi
may
necessari
support
refut
possibl
associ
viru
isol
diseas
virus
tissu
bodi
fluid
gener
detect
viru
host
tissu
csf
blood
vesicular
fluid
consid
highli
signific
recoveri
virus
cmv
urin
may
diagnost
signific
infectionfor
exampl
mump
viru
adenoviru
type
associ
acut
hemorrhag
cystiti
howev
recoveri
cmv
urin
also
difficult
interpret
cmv
isol
may
mere
reflect
activ
asymptomat
viru
replic
may
indic
signific
infect
patient
viruria
first
week
life
establish
diagnosi
congenit
cmv
infect
wherea
onset
viral
excret
week
life
reflect
intrapartum
postpartum
infect
diagnosi
acquir
cmv
infect
older
patient
usual
result
combin
find
includ
posit
cultur
site
ill
known
compat
cmv
reason
exclus
potenti
etiolog
agent
support
specif
serolog
histolog
data
viru
isol
site
upper
respiratori
tract
specimen
obtain
travers
upper
airway
vagin
fecal
cultur
vari
greatli
term
signific
one
extrem
isol
measl
mump
influenza
parinfluenza
rsv
signific
asymptomat
carriag
prolong
shed
virus
unusu
convers
virus
shed
without
symptom
period
rang
sever
week
enterovirus
mani
month
adenovirus
hsv
cmv
exampl
includ
hsv
cmv
oropharynx
vagina
adenovirus
oropharynx
intestin
tract
enterovirus
intestin
tract
vzv
hsv
cmv
adenovirus
ebv
may
remain
latent
long
period
becom
reactiv
respons
varieti
stress
stimuli
includ
infecti
agent
set
detect
may
signific
vzv
except
may
mere
repres
secondari
problem
complic
primari
infect
exampl
hsv
cold
sore
patient
bacteri
sepsi
adenoviru
isol
common
infant
young
children
base
epidemiolog
observ
serolog
respons
found
febril
resiratorv
svndrome
simultan
isol
agent
throat
fece
greater
probabl
associ
ill
isol
throat
fece
lesser
probabl
associ
isol
fece
least
diagnost
signific
latter
situat
interpret
signific
cultur
result
aid
adenoviru
serolog
studi
enterovirus
also
commonli
found
infant
children
particularli
late
summer
earli
autumn
season
knowledg
rel
frequenc
viru
shed
among
variou
age
group
particular
local
extrem
help
assess
signific
result
throat
stool
cultur
exampl
peak
preval
enterovirus
stool
toddler
late
summer
may
rang
greater
per
cent
subtrop
climat
per
cent
temper
zone
even
latter
area
carriag
rate
may
approach
per
cent
infant
period
enteroviru
activ
shed
enterovirus
throat
rel
transient
usual
week
wherea
fecal
shed
may
last
week
thu
clinic
compat
ill
isol
enteroviru
throat
support
stronger
tempor
relationship
diseas
isol
fece
echoviru
coxsackieviru
recov
stool
may
help
studi
patient
serum
antibodi
rise
particular
viral
isol
hsv
unusu
fecal
cultur
case
usual
repres
either
sever
dissemin
infect
br
infect
anu
perian
